(Q44670755)

5 December 2017

Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation (English)

1 reference

5 December 2017

0 references

Chun H Lau

1

1 reference

PubMed ID

14641155

5 December 2017

Marie Comer

series ordinal

2

1 reference

PubMed ID

14641155

5 December 2017

Susan Lightman

series ordinal

3

1 reference

5 December 2017

1 December 2003

1 reference

Clinical and Experimental Ophthalmology

5 December 2017

1 reference

5 December 2017

31

1 reference

5 December 2017

6

1 reference

5 December 2017

487-491

1 reference

New therapeutic options in uveitis

5 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-9071.2003.00704.X

Use of methotrexate in the management of sight-threatening uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-9071.2003.00704.X

Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-9071.2003.00704.X

The use of mycophenolate mofetil in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-9071.2003.00704.X

Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-9071.2003.00704.X

Mycophenolate mofetil and its mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-9071.2003.00704.X

Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-9071.2003.00704.X

10.1046/J.1442-9071.2003.00704.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference

PubMed ID

14641155